Organization
Bayer AG
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Bayer AG
... the major market players include: Agrium Inc. American Vanguard Corporation. BASF SE Bayer AG Chemtura Agrosolutions Dow Agrosciences LLC E. I. Du Pont De Nemours ...
... FMC Corporation, Syngenta International AG, Monsanto Company, DowDuPont Inc., BASF SE, and Bayer AG. In addition to opting for strategies on consolidating their shares, key ...
... product type, end-users, and regions. The market is dominated by Allergan Plc, Bayer AG, Merck & Co., Teva Pharmaceutical, and Church & Dwight, which has ...
... the board of directors of Casebia Therapeutics, CRISPR's 50-50 joint venture with Bayer AG. Dr. Novak is a serial entrepreneur and co-founded CRISPR Therapeutics in ...
... in the cancer immunotherapy market: - Medtronic Plc - Adaxic Inc - Bayer - Pfizer - Eli Lilly and Co. - Roche - Novartis - ...
... footprint worldwide. In a new study, Transparency Market Research (TMR) has identified Bayer AG, Pfizer Inc., Sanofi, GlaxoSmithKline Plc. (GSK), Merck & Co., Inc., AstraZeneca, ...
... Associates Of Cape Cod Inc. Astex Pharmaceuticals Inc. AstraZeneca Plc ASYMPTOTE LTD Bayer AG Bayer Corporation Bayer HealthCare AG Bayer Schering Pharma Aktiengesellschaft BioLife Solutions, ...
... WILMINGTON, Del. — Johnson & Johnson and Bayer AG are responsible for a woman's injuries tied to the blood-thinning drug ...
... Industries, Ltd., Merck & Co., Inc., FMC Corporation, Arysta Lifescience, BASF SE, Bayer AG, Chemtura Corporation and Dupont. What The Report Offers: Market share assessments ...
... Leverkusen/St. Louis - Bayer and Monsanto (NYSE: MON) today announced that the Committee on Foreign Investment ...
... dedicated strategic business unit oncology earlier this year within its pharmaceuticals division, Bayer announced today to further strengthen its strategic pharmaceutical research and development activities ...
... welcomed by some analysts. FiercePharma BayerJoerg Moeller will become head of R&D. Bayer is changing its R&D organization days after making big bets potentially worth ...
... large number of players. However, some major market players are AstraZeneca plc., Bayer AG, Cubist Pharmaceuticals, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Pharmaceuticals Ltd., Johnson & ...
... combination of aflibercept and nesvacumab is being jointly developed by Regeneron and Bayer AG under a global collaboration agreement. The safety and efficacy of the ...
... growing population. The key players in the global glyphosate market are Bayer CropScience AG, BASF SE, Syngenta (Subsidiary of ChemChina), FMC corporation, Monsanto Company (Part ...
... plc., Pfizer Inc., Novartis AG, Merck & Co., Inc., Bristol-Myers Squibb Company, Bayer AG, Sanofi, Boehringer Ingelheim GmbH, F. Hoffmann-La Roche Ltd, Abbott Laboratories, Gilead ...
... that it has entered into a multi-target discovery collaboration with Germany-based Bayer AG ("Bayer")(ETR:BAYN). Under the agreement, PeptiDream will use its proprietary Peptide Discovery Platform ...
... take Young’s place. FiercePharma BayerHeiko Schipper will become head of consumer health. Bayer is facing challenges with its consumer health business in the U.S. Sales ...
... Leverkusen - The Supervisory Board of Bayer AG has appointed Heiko Schipper (48) to the Board of Management of ...
... General Report Contents The transcervical implant market in Europe currently consists of Bayer AG as the sole competitor offering the Essure® procedure. Essure® was first ...
... driven by growing middle class population. Companies discussed in this research at Bayer AG, Merck & Co., Inc., Dechra Pharmaceuticals PLC, Boehringer Ingelheim GmbH, Eli ...
... for serious diseases, Casebia Therapeutics, a joint-venture established by CRISPR Therapeutics and Bayer AG for developing CRISPR-based therapeutics in select disease areas, and CureVac AG, ...
... the ACC Executive Committee Jan. 1. MacCleary joined Covestro (then part of Bayer) in 1979 as an accountant, before embarking on a diverse career path ...
... decrease in interest expense of $8.0Â million from the convertible loan with Bayer. Collaboration revenue for the nine months ended September 30, 2017 was $8.7 ...
Want to see the full history on Bayer AG? Upgrade to RelSci Pro now!
Start My Free Trial